Press release
The Neuropathic Pain Market to get driven by Machine Learning
Reaching the revenues of over US$ 6 Bn at the end of 2019, the global neuropathic pain management market is projected for a healthy CAGR during the forecast period (2019 – 2029). Increasing prevalence of neuropathic pain disorders and growing awareness about pain medication are boosting the demand for pain management drugs.
Planning Forward? Access Sample Of Neuropathic Pain Market Report! https://www.persistencemarketresearch.com/samples/4149
Pipeline strategies by manufacturers are focused on introducing advanced drugs with minimum side effects to increase market share. For instance, Pfizer sponsored drug Pregabalin, effective in treating neuropathic (nerve) pain resulting from peripheral nerve trauma that is in phase 3 clinical trials. Increasing research and development activities to develop medications for indications such as post-herpetic neuralgia are creating significant opportunities for manufactures to flourish in the market.
Company Profiles:
Pfizer Inc.
Johnson & Johnson Services, Inc.
Bristol-Myers Squibb Company
Sanofi S.A
GlaxoSmithKline plc
Eli Lilly and Company
Teva Pharmaceutical Industries Ltd
Baxter International Inc
How About Revitalizing The Strategy-Oriented Funnel To Stay Ahead In The Neuropathic Pain Market? https://www.persistencemarketresearch.com/methodology/4149
Key Takeaways – Neuropathic Pain Management Market Study
Attributed to less side effects, tricyclic antidepressant drugs are expected to be popular as compared to opioids and steroids during the forecast period.
North America is expected to be significant revenue generator owing to emergence of several regional market players and well-developed healthcare infrastructure.
Retail pharmacies are expected to be dominant distribution channels in the neuropathic pain management market.
Increasing prevalence of diabetic neuropathy and availability of approved neuropathy pain medications have significantly added to the opportunities for market growth, thereby fostering the rate of adoption of neuropathic pain management drugs.
Planning To Introduce An Offbeat Product/Technology In The Neuropathic Pain Market? Go To “Purchase Now” To Have Our Neuropathic Pain Market Report! https://www.persistencemarketresearch.com/checkout/4149
Increasing R&D Spending by Pharmaceuticals Companies Shaping Future
One of the key factors observed to impact the neuropathic pain management market growth is the development of new drugs for treatment of neuropathic and chronic pains. Companies are focusing on clinical trials to develop drugs for efficient treatment of neuropathic pain. For instance, Eli Lilly and Company developed Duloxetine (LY248686) for Diabetic Peripheral Neuropathic Pain (DPNP) that is under phase 4 clinical trial.
At the same time, companies are focused on expanding therapeutic applications of drugs such as opioids and steroids for neuropathic pain management without causing any serious side effects to patients. Currently, more than 100 clinical trials are been carried out for pain management. Among those clinical trials, nearly half of the clinical trials are for various indications of neuropathic pain such as diabetic neuropathy and post-herpetic neuralgia.
Complete Report Details@ https://www.persistencemarketresearch.com/market-research/neuropathic-pain-market.asp
What Does the Report Cover?
The neuropathic pain management market, a new study from Persistence Market Research, provides unparalleled insights on evolution of the neuropathic pain management market during 2014 – 2018 and presents demand projections during 2019 – 2029 on the basis of drug class (tricyclic anti-depressants, anticonvulsants, SNRI’s, capsaicin cream, local anesthesia, opioids, steroids, and others), indication (diabetic neuropathy, trigeminal neuralgia, post-herpetic neuralgia, chemotherapy-induced peripheral neuropathy and others), distribution channel (retail pharmacies, hospital pharmacies, and online pharmacies) across prominent regions (North America, Latin America, Europe, Asia Pacific and MEA).
Related Reports:
Autogenous Vaccine For Aquaculture Market - https://www.persistencemarketresearch.com/market-research/autogenous-vaccine-for-aquaculture-market.asp
Post Herpetic Neuralgia Treatment Market - https://www.persistencemarketresearch.com/market-research/post-herpetic-neuralgia-treatment-market.asp
Contact Us:
Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com
About Us:
Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release The Neuropathic Pain Market to get driven by Machine Learning here
News-ID: 2526894 • Views: …
More Releases from Persistence Market Research
Gum Arabic Market Growth Driven by Natural Additives Demand to Reach $86.1 Mn by …
The global gum arabic market is witnessing a steady upsurge, projected to increase from US$56.5 million in 2024 to US$86.1 million by 2031. This marks a compound annual growth rate (CAGR) of 6.2% during the forecast period (2024-2031). Gum arabic, a natural exudate derived primarily from Acacia Senegal and Acacia Seyal trees, continues to gain traction across multiple industries due to its superior emulsifying, stabilizing, and binding properties. Rising demand…
Calcite Market Size Worth USD 21.2 Billion by 2032 - Persistence Market Research
The global calcite market is witnessing steady growth due to its expanding use across diverse industries such as construction, plastics, paper, paints and coatings, and adhesives. Calcite, a crystalline form of calcium carbonate, serves as one of the most abundant and versatile minerals, offering properties like high purity, whiteness, and chemical stability that make it a key filler and functional additive in various applications.
Get a Sample PDF Brochure of the…
Microwave Absorbing Materials Market to Reach US$691.9 Million by 2032 - Persist …
The global microwave absorbing materials market is experiencing rapid growth due to the rising demand for electromagnetic interference control across multiple industries. As the integration of electronic systems in various applications continues to expand, managing electromagnetic emissions has become critical for ensuring efficient operation, reliability, and safety. Microwave absorbing materials are designed to reduce unwanted electromagnetic waves by absorbing and dissipating their energy. These advanced materials play a key role…
Polytetrahydrofuran Market Valued at US$5.6 Billion in 2025, Projected to Reach …
The global chemical industry is undergoing a significant transformation as innovation, sustainability, and performance requirements reshape product development. Among the many specialty polymers driving this evolution, Polytetrahydrofuran has emerged as a highly versatile material used across diverse industrial applications. Commonly known as PolyTHF or PTMEG, this polymer is a key intermediate for producing elastic fibers, thermoplastic polyurethanes, coatings, and elastomers. Its ability to impart flexibility, resilience, and abrasion resistance makes…
More Releases for Neuropathic
Neuropathic Pain Management Market Size Analysis by Application, Type, and Regio …
USA, New Jersey- According to Market Research Intellect, the global Neuropathic Pain Management market in the Internet, Communication and Technology category is projected to witness significant growth from 2025 to 2032. Market dynamics, technological advancements, and evolving consumer demand are expected to drive expansion during this period.
The neuropathic pain management market is experiencing consistent growth due to rising incidences of chronic conditions such as diabetes, cancer, and neurological disorders, which…
Neuropathic Pain Market New Therapeutic Developments and Treatments
On April 08, 2025, Exactitude Consultancy., Ltd. announces the release of the report "Global Neuropathic Pain Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2034". The report is a detailed and comprehensive analysis presented by region and country, type and application. As the market is constantly changing, the report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across…
Neuropathic Pain Market: Innovative Therapies Reshaping Chronic Pain Management
In recent years, the global Neuropathic Pain Market has witnessed a dynamic shift, influenced by changing consumer preferences, technological advancements, and a growing emphasis on sustainability. The Research report on Neuropathic Pain Market presents a complete judgment of the market through strategic insights on future trends, growth factors, supplier landscape, demand landscape, Y-o-Y growth rate, CAGR, pricing analysis. It also provides and a lot of business matrices including…
The increase in Neuropathic Ocular Pain Market Size is a direct consequence of i …
As per DelveInsight, the Neuropathic Ocular Pain Market is anticipated to grow in the coming years owing to the rise in the number of prevalent cases in the 7MM, the improvement in the research and development activities, and the launch of novel therapies in the Neuropathic Ocular Pain market. There are several key players involved in developing therapies for Neuropathic Ocular Pain, like Novartis, and others.
The Neuropathic Ocular Pain market…
Neuropathic Pain Market Growth Factors and Manufacturers
Neuropathic Pain Market 2022
Global Neuropathic Pain Market to Reach US$ 8.3 Bn by 2024 End.
Machine learning and artificial intelligence have been transforming the healthcare vertical since the last few years. AI-powered healthcare solutions are there to help the patients with automation of routine tasks and data analysis. Wearable technologies are a part of exclusive physiotherapy devices that are capable of tracking and analyzing specific movements of the patients. This would…
Global Neuropathic Pain Market Research Report Forecast to 2023
Neuropathic Pain Market 2020 comprises a detailed survey of the Neuropathic Pain Market size, share, trends, extension, consumption, and share, segments, application and Forecast 2025.
Global "Neuropathic Pain" Market 2020-2025 Report contains all demographic as well as analytical data regarding market review, growth, demand, and budget analysis. The report mainly highlights the significant trends of the Neuropathic Pain market in terms of thriving companies, business methods, product values and pricing, revenue,…
